Suchergebnisse - "Falchi, Federico"

PubPharm (65)

1

Probing allosteric communication with combined molecular dynamics simulations and network analysis

enthalten in: Current opinion in structural biology | 2024

von Bernetti, M. | Bosio, S. | Bresciani, V. | +2

2

Innovative Strategy toward Mutant CFTR Rescue in Cystic Fibrosis : Design and Synthesis of Thiadiazole Inhibitors of the E3 Ligase RNF5

enthalten in: Journal of medicinal chemistry | 2023

von Brusa, I. | Sondo, E. | Pesce, E. | +13

3

Proteostasis Regulators in Cystic Fibrosis : Current Development and Future Perspectives

enthalten in: Journal of medicinal chemistry | 2022

von Brusa, I. | Sondo, E. | Falchi, F. | +3

4

Divide et Impera: Identification of Small-Molecule Inhibitors of HCMV Replication Interfering with Dimerization of DNA Polymerase Processivity Factor UL44

enthalten in: bioRxiv.org | 2021

von Ghassabian, H. | Falchi, F. | Antonio, V. | +5

5

Searching for New Microbiome-Targeted Therapeutics through a Drug Repurposing Approach

enthalten in: Journal of medicinal chemistry | 2021

von Barone, M. | Rampelli, S. | Biagi, E. | +7

6

COVID-19 Repurposed Therapeutics Targeting the Viral Protease and Spike-protein:ACE2 Interface using MD-based Pharmacophore and Consensus Virtual Screening

enthalten in: chemRxiv.org | 2021

von garabato, b. | Falchi, F. | Cavalli, A.

7

Divide et impera : An In Silico Screening Targeting HCMV ppUL44 Processivity Factor Homodimerization Identifies Small Molecules Inhibiting Viral Replication

enthalten in: Viruses | 2021

von Ghassabian, H. | Falchi, F. | Timmoneri, M. | +4

8

Divide et Impera: An In Silico Screening Targeting HCMV ppUL44 Processivity Factor Homodimerization Identifies Small Molecules Inhibiting Viral Replication

enthalten in: Preprints.org | 2020

von Ghassabian, H. | Falchi, F. | Timmoneri, M. | +4

9

Targeting the Protein Tunnels of the Urease Accessory Complex : A Theoretical Investigation

enthalten in: Molecules (Basel, Switzerland) | 2020

von Masetti, M. | Falchi, F. | Gioia, D. | +3

10

Synthetic Lethality in Pancreatic Cancer : Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib

enthalten in: Journal of medicinal chemistry | 2020

von Bagnolini, G. | Milano, D. | Manerba, M. | +16

1
2
3
4
5
6
7
Nächster »
[7]